Maureen Newman is a science columnist for Pulmonary Hypertension News. She is currently a PhD student studying biomedical engineering at University of Rochester, working towards a career of research in biomaterials for drug delivery and regenerative medicine. She is an integral part of Dr. Danielle Benoit’s laboratory, where she is investigating bone-homing therapeutics for osteoporosis treatment.
New guidelines from the American Society for Radiation Oncology (ASTRO) answer five key questions related to the role of definitive and adjuvant radiation therapy in treating locally advanced non-small ... Read more
A biomolecular signaling pathway long associated with lung cancer is under investigation at Rensselaer Polytechnic Institute. The laboratory of Dr. Chunyu Wang, an associate professor in biological sciences at ... Read more
If scientists and researchers understood the molecular mechanisms of tumorigenesis, lung cancer could be eradicated. A recent study made one more step forward in the goal of understanding lung ... Read more
When patients are diagnosed with lung cancer, a simple test for serum biomarkers may be useful to determine a prognosis. Plasma proteins can indicate underlying tissue abnormalities, giving a ... Read more
Although the genetic code held within DNA contributes largely to risk factors for developing non-small cell lung cancer (NSCLC), external manipulation of DNA, known as epigenetics, plays an equally ... Read more
Every cup of coffee may contain a strong agent that is effective at increasing the efficacy of anti-lung cancer medication: caffeine. This finding was part of a new study from Wayne ... Read more